This suggests that in the micro-environment of the lymph node, BCR triggering occurs for both IGHV mutated and IGHV unmutated CLL cells, from what we would predict that miRNA signatures in the lymph node will be different from those published using CLL cells freshly isolated from peripheral blood. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.